Dynamic Neuromuscular Stabilization vs Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence
NCT07075900
Behavior, Dynamic Neuromuscular Stabilization
Izmir, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT01971294
Urinary symptoms must be frequent in Scleroderma. In one hand, mobility limitation by joint stiffness and skin sclerosis, forced diuresis due to heart involvement (cardiomyopathy or pulmonary hypertension), diuretics use and corticoid-induced hyperglycaemia, as well as narcotic medication use, puts patients at higher risk of secondary bladder filling and voiding dysfunction. In another hand, few case report and small sample observational studies have identified a specific sclerosis of the urinary tract. Those two mechanisms must be more frequent in the diffuse cutaneous form of scleroderma (dcSSc) compare to the limited one (lcSSc). But prevalence or incidence is unknown.
Urinary symptoms are seldom reported by those suffering from them and are rarely part of a systemic evaluation. In a threatening disease, urinary symptoms assessment might seem to be of no priority. But LUTS have a real impact on many aspect of everyday living. Furthermore urinary tract involvement might predispose to urinary tract infection due to flow limitation and stagnation. Since it is an inner fibrosis it might be associated with a more aggressive form of disease conferring a greater loss of physical function, higher risk for hospital admission and death.
Thus, identifying urinary symptoms would permit to address specific rehabilitation or medication therapy, in order to minimize the consequences of the bothersome symptoms and identify those subjects at higher risk of urinary infection, aggressive disease/loss of function or death.
This study will also give basement to build an interventional study directed toward LUTS treatment in this population.
In this prospective cohort we would like to:
* Compare the prevalence of lower urinary tract symptoms (LUTS) in diffuse and limited forms of systemic sclerosis. * Determine the prevalence (at inclusion) and incidence (in a two years period) of LUTS among patients suffering from systemic sclerosis. * Evaluate the impact of LUTS symptoms on Quality of life. * Compare the discrimination ability of Cochin-hand score and HAQ score to predict incontinence in this population. * Evaluate the association between LUTS symptoms, hospital admission rate, urinary tract infection, mortality and loss of autonomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hôpital Cochin, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adult suffering from systemic sclerosis included in network of Brescia (I), Geneva (CH), Padova (I) and Paris (F).
Exclusion criteria
Those unable to understand the rules and implications of the study, end of life patients, the pregnant women and anuric patients
Time frame: Inclusion and every year for 2 years
Time frame: At inclusion and after 2 years
Quality of life (lower, better)
Time frame: During two years
Time frame: During two years
Time frame: At inclusion and after 2 years
Quality of life (0-100; higher, better), specific for urinary incontinence
University Hospital, Geneva
Other
Lower Urinary Tract Symptoms in Patients Suffering From Systemic Sclerosis: a Multi-centric Longitudinal Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07075900
Behavior, Dynamic Neuromuscular Stabilization
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07009249
Biofeedback Training, Dynamic Neuromuscular Stabilization
Izmir, İzmir, Turkey (Türkiye)
View Trial DetailsNCT06815107
Tolerance, Ureteral Double-J Stent
Amiens, France
View Trial DetailsNCT04301596
Connective Tissue Diseases, Scleroderma, Systemic
Montpellier, France
View Trial Details